|
Volumn 4, Issue 6, 2009, Pages 773-775
|
Long lasting response to the multikinase inhibitor bay 43-9006 (Sorafenib) in a heavily pretreated metastatic thymic carcinoma
|
Author keywords
C Kit; CD117; Thymic carcinoma; Thymoma; Tyrosine kinase
|
Indexed keywords
CISPLATIN;
DOXORUBICIN;
ETOPOSIDE;
IFOSFAMIDE;
OCTREOTIDE;
SORAFENIB;
BENZENESULFONIC ACID DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PYRIDINE DERIVATIVE;
STEM CELL FACTOR RECEPTOR;
VASCULOTROPIN RECEPTOR;
ADULT;
ADVANCED CANCER;
ARTICLE;
CAPSULE ENDOSCOPE;
CASE REPORT;
DIARRHEA;
DRUG EFFICACY;
DRUG WITHDRAWAL;
EXCISION;
EXON;
FATIGUE;
HUMAN;
IMMUNOHISTOCHEMISTRY;
IMMUNOREACTIVITY;
LIVER METASTASIS;
LUNG METASTASIS;
MALE;
MISSENSE MUTATION;
MULTIPLE CYCLE TREATMENT;
PREDICTION;
PRIORITY JOURNAL;
PRURITUS;
RADIOFREQUENCY ABLATION;
SKIN EXFOLIATION;
SKIN TOXICITY;
THYMUS CANCER;
TREATMENT RESPONSE;
TREATMENT WITHDRAWAL;
TUMOR CELL;
TUMOR VOLUME;
DRUG ANTAGONISM;
GENETICS;
METASTASIS;
MIDDLE AGED;
MOLECULAR GENETICS;
NUCLEOTIDE SEQUENCE;
THYMOMA;
BASE SEQUENCE;
BENZENESULFONATES;
HUMANS;
MALE;
MIDDLE AGED;
MOLECULAR SEQUENCE DATA;
MUTATION, MISSENSE;
PROTEIN KINASE INHIBITORS;
PROTO-ONCOGENE PROTEINS C-KIT;
PYRIDINES;
RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;
THYMOMA;
THYMUS NEOPLASMS;
|
EID: 67849108379
PISSN: 15560864
EISSN: 15561380
Source Type: Journal
DOI: 10.1097/JTO.0b013e3181a52e25 Document Type: Article |
Times cited : (73)
|
References (9)
|